Ectica Technologies

Biotechnology1-10 emp.
HQZürich, Zurich, Switzerland
Founded2015 · EN
WebsiteLinkedIn

Unlock innovative cancer research opportunities with cutting-edge hydrogels.

They specialize in advanced synthetic hydrogels designed for cancer research and drug discovery. Their patented 3DProSeed® platform replicates the tumor microenvironment, enhancing drug screening processes. Partnering with them could empower pre-clinical CROs and biopharma companies to elevate their research capabilities and explore new horizons in oncology and fibrosis. Together, they could pioneer breakthroughs in therapeutic development.